Art
J-GLOBAL ID:201802271670907514   Reference number:18A1211413

Antitumor Effects of Laminaria Extract Fucoxanthin on Lung Cancer

肺癌に対するLaminaria抽出物フコキサンチンの抗腫瘍効果【JST・京大機械翻訳】
Author (6):
Material:
Volume: 15  Issue:Page: 39  Publication year: 2017 
JST Material Number: U7236A  ISSN: 1660-3397  Document type: Article
Article type: 原著論文  Country of issue: Switzerland (CHE)  Language: ENGLISH (EN)
Abstract/Point:
Abstract/Point
Japanese summary of the article(about several hundred characters).
All summary is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
Lung cancer is the leading cau...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A1211413&from=J-GLOBAL&jstjournalNo=U7236A") }}
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.

Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
, 【Automatic Indexing@JST】
JST classification (2):
JST classification
Category name(code) classified by JST.
Basic research of antitumor(=antineoplastic)drugs  ,  Experimental treatment for tumors 
Substance index (1):
Substance index
Chemical Substance indexed to the Article.
Reference (42):
  • Chen, W.; Zheng, R.; Baade, P.D.; Zhang, S.; Zeng, H.; Bray, F.; Jemal, A.; Yu, X.Q.; He, J. Cancer statistics in china, 2015. CA Cancer J. Clin. 2016, 66, 115-132.
  • Chang, G.-C.; Chen, K.-C.; Yang, T.-Y.; Yin, M.-C.; Lin, C.-P.; Kuo, B.I.-T.; Hsu, J.-Y. Activity of gefitinib in advanced non-small-cell lung cancer with very poor performance status. Investig. New Drugs 2005, 23, 73-77.
  • Pignon, J.-P.; Tribodet, H.; Scagliotti, G.V.; Douillard, J.-Y.; Shepherd, F.A.; Stephens, R.J.; Dunant, A.; Torri, V.; Rosell, R.; Seymour, L. Lung adjuvant cisplatin evaluation: A pooled analysis by the lace collaborative group. J. Clin. Oncol. 2008, 26, 3552-3559.
  • De Mello, R.A.; Veloso, A.F.; Catarina, P.E.; Nadine, S.; Antoniou, G. Potential role of immunotherapy in advanced non-small-cell lung cancer. Oncol. Targets Ther. 2017, 10, 21-30.
  • Dholaria, B.; Hammond, W.; Shreders, A.; Lou, Y. Emerging therapeutic agents for lung cancer. J. Hematol. Oncol. 2016, 9, 138.
more...
Terms in the title (5):
Terms in the title
Keywords automatically extracted from the title.

Return to Previous Page